The risk stratification of AML include mutations of the genes; NMP1, FLT3, CEPBA, RUNX1, ASLX1, TP53 associated with cytogenetic abnormalities or normal karyotypes4,6,9. This evidence concerns the gene RUNX1 and acute myeloid leukemia.